Also trades as: INFI (NASDAQ) · $vol 0M
INFIQ Earnings
Infinity Pharmaceuticals, Inc.
1W: -99.0%
1M: -99.0%
3M: +0.0%
YTD: -99.0%
1Y: -98.0%
3Y: -100.0%
5Y: -100.0%
$0.00
+0.00 (+0.00%)
Weekly Expected Move ±9113.7%
$-0
$-0
$0
$0
$0
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Next Earnings
2026-11-16
EPS Estimate
$-0.14
Range: $-0.14 - $-0.14
Revenue Estimate
$239K
1 analysts
Estimate vs Actual
Earnings Surprise History
Wall Street Forward Estimates
Quarterly
Annual
Estimate Revisions
Recent Revisions
| Date | Period | Fiscal Date | EPS Old | EPS New | Change | Rev Old | Rev New |
|---|---|---|---|---|---|---|---|
| 2026-09-30 | quarter | 2029-03-30 | $-0.12 | $-0.12 | — | $800,000 | $700,000 |
| 2026-09-30 | quarter | 2026-09-30 | $-0.14 | $-0.12 | ▲ 0.02 | $239,429 | $1,277,400 |
| 2026-09-30 | quarter | 2029-06-30 | $-0.13 | $-0.12 | ▲ 0.01 | $800,000 | $800,000 |
| 2026-09-30 | quarter | 2026-12-30 | $-0.14 | $-0.14 | — | $393,429 | $239,429 |
| 2026-09-30 | quarter | 2027-03-30 | $-0.14 | $-0.14 | — | $301,500 | $393,429 |
| 2026-09-30 | quarter | 2027-09-30 | $-0.13 | $-0.14 | ▼ 0.01 | $509,399 | $295,857 |
| 2026-09-30 | quarter | 2028-06-30 | $-0.10 | $-0.03 | ▲ 0.07 | $300,000 | $8,050,000 |
| 2026-09-30 | quarter | 2030-06-30 | $— | $-0.15 | ▼ 0.15 | $— | $1,000,000 |
| 2026-09-30 | quarter | 2029-09-30 | $-0.13 | $-0.13 | — | $900,000 | $800,000 |
| 2026-09-30 | quarter | 2028-09-30 | $-0.12 | $-0.10 | ▲ 0.02 | $700,000 | $300,000 |
| 2026-09-30 | quarter | 2028-03-30 | $-0.03 | $-0.06 | ▼ 0.03 | $8,050,000 | $6,188,500 |
| 2026-09-30 | quarter | 2027-06-30 | $-0.14 | $-0.14 | — | $295,857 | $301,500 |
| 2026-09-30 | quarter | 2029-12-30 | $-0.14 | $-0.13 | ▲ 0.01 | $900,000 | $900,000 |
| 2026-09-30 | quarter | 2027-12-30 | $-0.06 | $-0.13 | ▼ 0.07 | $6,188,500 | $509,399 |
| 2026-09-30 | quarter | 2030-03-30 | $-0.15 | $-0.14 | ▲ 0.01 | $1,000,000 | $900,000 |
Earnings Call Transcripts
No transcripts available.